Calif. Dx firm raises funds for prostate cancer test

10/1/2013 | GenomeWeb Daily News (free registration)

GenomeDx Biosciences has secured an undisclosed amount in a Series B round of financing led by Merck Global Health Innovation Fund. The San Diego company will use the funding to support commercial growth of its Decipher test, designed to predict a patient's risk of developing prostate cancer.

View Full Article in:

GenomeWeb Daily News (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Executive Officer
CarePoint Health Plan
Jersey City, NJ
Regional Director, Southeastern Region - State Affairs
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Director, Compliance - Health Plan Privacy & Security
Kaiser Permanente
Oakland, CA